Elevated CA125 levels in patients with metastatic breast carcinoma
Open Access
- 1 October 1990
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 62 (4), 668-670
- https://doi.org/10.1038/bjc.1990.353
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- COMPARISON OF CA15-3 AND CARCINOEMBRYONIC ANTIGEN IN MONITORING THE CLINICAL COURSE OF PATIENTS WITH METASTATIC BREAST-CANCER1988
- CA125 as a serum marker for poor prognosis in ovarian malignanciesGynecologic Oncology, 1987
- Clinical Evaluation of an Immunoradiometric Assay for CA15-3 Antigen Associated With Human Mammary Carcinomas: Comparison With Carcinoembryonic AntigenJapanese Journal of Clinical Oncology, 1986
- Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.Journal of Clinical Oncology, 1986
- Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1985
- CA125 seric levels in non malignant pathologies.1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Sandwich enzyme immunoassay using three monoclonal antibodies against different epitopes of carcinoembryonic antigen (CEA)Immunology Letters, 1982
- Reporting results of cancer treatmentCancer, 1981
- Sequential Carcinoembryonic Antigen Levels in the Therapy of Metastatic Breast CancerAnnals of Internal Medicine, 1978